Comparative Pharmacology
Head-to-head clinical analysis: POTASSIUM IODIDE versus TAPAZOLE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: POTASSIUM IODIDE versus TAPAZOLE.
POTASSIUM IODIDE vs TAPAZOLE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Potassium iodide suppresses thyroid hormone synthesis and release via the Wolff-Chaikoff effect, inhibiting iodide organification and reducing vascularity of the thyroid gland.
Inhibits thyroid peroxidase, thereby blocking the synthesis of thyroid hormones (T3 and T4) and reducing iodine organification and coupling of iodotyrosines.
Oral: 300 mg (0.3 mL of saturated solution) three times daily for thyroid protection in radiation exposure; for hyperthyroidism preoperative: 60-250 mg (0.06-0.25 mL) three times daily.
15-40 mg per day orally in 3 divided doses; maintenance: 5-15 mg per day orally once daily.
None Documented
None Documented
Terminal half-life in euthyroid individuals is approximately 13 days (range 10–15 days). In hyperthyroidism, half-life may be shortened to 5–6 days due to increased thyroid clearance; in hypothyroidism, half-life may be prolonged up to 40 days.
Clinical Note
moderateWarfarin + Potassium Iodide
"Warfarin may decrease the anticoagulant activities of Potassium Iodide."
Clinical Note
moderatePhenprocoumon + Potassium Iodide
"Phenprocoumon may decrease the anticoagulant activities of Potassium Iodide."
Clinical Note
moderatePhenindione + Potassium Iodide
"Phenindione may decrease the anticoagulant activities of Potassium Iodide."
Clinical Note
moderateAcenocoumarol + Potassium Iodide
3-6 hours; clinically, effects persist longer due to intrathyroidal accumulation.
Renal: >90% of absorbed iodide is excreted in urine; fecal elimination is negligible (<2%).
Primarily renal, approximately 65% excreted in urine as metabolites and unchanged drug; <10% eliminated in feces via biliary excretion.
Category C
Category C
Antithyroid Agent
Antithyroid Agent
"Acenocoumarol may decrease the anticoagulant activities of Potassium Iodide."